Lymphocyte aggregates persist and accumulate in the lungs of patients with idiopathic pulmonary fibrosis

Journal of Inflammation Research

Volumn 6, Issue 1, 2013, Pages 63-70

  Todd, Nevins W ^a,b   Scheraga, Rachel G ^a,c   Galvin, Jeffrey R ^a   Iacono, Aldo T ^a   James Britt, E ^a   Luzina, Irina G ^a,b   Burke, Allen P ^a   Atamas, Sergei P ^a,b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b BALTIMORE VA MEDICAL CENTER   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Idiopathic pulmonary fibrosis; Inflammation; Lymphocyte aggregates

Indexed keywords

CD20 ANTIGEN; CD3 ANTIGEN; CD68 ANTIGEN;

ADULT; AGED; ARTICLE; CD3+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; EXPLANT; FEMALE; FIBROBLAST; FIBROSING ALVEOLITIS; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEUKOCYTE AGGREGATION; LUNG BIOPSY; LUNG TRANSPLANTATION; LYMPHOCYTIC INFILTRATION; MALE; QUANTITATIVE ANALYSIS; SCORING SYSTEM;

EID: 84875651435     PISSN: None     EISSN: 11787031     Source Type: Journal    
DOI: 10.2147/JIR.S40673     Document Type: Article

References (27)

1. American Thoracic Society, European Respiratory Society. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, Jun 2001 and by the ERS Executive Committee, Jun 2001. Am J Respir Crit Care Med. 2002;165(2):277-304.
2. Myers JL, Katzenstein AL. Beyond a consensus classification for idiopathic interstitial pneumonias: progress and controversies. Histopathology. 2009;54(1):90-103.
3. Raghu G, Collard HR, Egan JJ, etal. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183(6):788-824.
4. Scadding JG, Hinson KF. Diffuse fibrosing alveolitis (diffuse interstitial fibrosis of the lungs). Correlation of histology at biopsy with prognosis. Thorax. 1967;22(4):291-304.
5. Crystal RG, Fulmer JD, Roberts WC, Moss ML, Line BR, Reynolds HY. Idiopathic pulmonary fibrosis. Clinical, histologic, radiographic, physiologic, scintigraphic, cytologic, and biochemical aspects. Ann Intern Med. 1976;85(6):769-788.
6. Katzenstein AL, Zisman D, Litzky L, Nguyen B, Kotloff R. Usual interstitial pneumonia: histologic study of biopsy and explant specimens. Am J Surg Pathol. 2002;26(12):1567-1577.
7. Marchal-Sommé J, Uzunhan Y, Marchand-Adam S, etal. Cutting edge: nonproliferating mature immune cells form a novel type of organized lymphoid structure in idiopathic pulmonary fibrosis. J Immunol. 2006; 176(10):5735-5739.
8. Homer RJ, Elias JA, Lee CG, Herzog E. Modern concepts on the role of inflammation in pulmonary fibrosis. Arch Pathol Lab Med. 2011; 135(6):780-788.
9. Wynn TA. Integrating mechanisms of pulmonary fibrosis. J Exp Med. 2011;208(7):1339-1350.
10. Crooks MG, Aslam I, Hart SP. Inflammation and pulmonary fibrosis. In: Khatami M, editor. Inflammatory Diseases-Immunopathology, Clinical and Pharmacological Bases. Rijeka: Intech; 2012:99-128.
11. Todd NW, Luzina IG, Atamas SP. Molecular and cellular mechanisms of pulmonary fibrosis. Fibrogenesis Tissue Repair. 2012;5(1):11.
12. Meliconi R, Lalli E, Borzì RM, etal. Idiopathic pulmonary fibrosis: can cell mediated immunity markers predict clinical outcome? Thorax. 1990;45(7):536-540.
13. Flaherty KR, Travis WD, Colby TV, etal. Histopathologic variability in usual and nonspecific interstitial pneumonias. Am J Respir Crit Care Med. 2001;164(9):1722-1727.
14. Strieter RM. Pathogenesis and natural history of usual interstitial pneumonia: the whole story or the last chapter of a long novel. Chest. 2005;128(5 Suppl 1):S526-S532.
15. Rasband WS. Image J. US National Institutes of Health, Bethesda, Maryland, USA; 1997-2012. http://imagej.nih.gov/ij/. Accessed January 25, 2013.
16. Selman M, King TE, Pardo A; American Thoracic Society; European Respiratory Society; American College of Chest Physicians. Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med. 2001;134(2):136-151.
17. Gauldie J. Pro: Inflammatory mechanisms are a minor component of the pathogenesis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2002;165(9):1205-1206.
18. Noble PW, Homer RJ. Idiopathic pulmonary fibrosis: new insights into pathogenesis. Clin Chest Med. 2004;25(4):749-758.
19. Luzina IG, Todd NW, Iacono AT, Atamas SP. Roles of T lymphocytes in pulmonary fibrosis. J Leukoc Biol. 2008;83(2):237-244.
20. Luzina IG, Todd NW, Nacu N, etal. Regulation of pulmonary inflammation and fibrosis through expression of integrins alphaVbeta3 and alphaVbeta5 on pulmonary T lymphocytes. Arthritis Rheum. 2009; 60(5):1530-1539.
21. Pochetuhen K, Luzina IG, Lockatell V, Choi J, Todd NW, Atamas SP. Complex regulation of pulmonary inflammation and fibrosis by CCL18. Am J Pathol. 2007;171(2):428-437.
22. Luzina IG, Papadimitriou JC, Anderson R, Pochetuhen K, Atamas SP. Induction of prolonged infiltration of T lymphocytes and transient T lymphocyte-dependent collagen deposition in mouse lungs following adenoviral gene transfer of CCL18. Arthritis Rheum. 2006;54(8):2643-2655.
23. Atamas SP, Yurovsky VV, Wise R, etal. Production of type 2 cytokines by CD8+ lung cells is associated with greater decline in pulmonary function in patients with systemic sclerosis. Arthritis Rheum. 1999;42(6): 1168-1178.
24. Daniil Z, Kitsanta P, Kapotsis G, etal. CD8+ T lymphocytes in lung tissue from patients with idiopathic pulmonary fibrosis. Respir Res. 2005;6:81.
25. Parra ER, Kairalla RA, Ribeiro de Carvalho CR, Eher E, Capelozzi VL. Inflammatory cell phenotyping of the pulmonary interstitium in idiopathic interstitial pneumonia. Respiration. 2007;74(2):159-169.
26. Barnes PJ, Adcock IM. Glucocorticoid resistance in inflammatory diseases. Lancet. 2009;373(9678):1905-1917.
27. Ito K, Hanazawa T, Tomita K, Barnes PJ, Adcock IM. Oxidative stress reduces histone deacetylase 2 activity and enhances IL-8 gene expression: role of tyrosine nitration. Biochem Biophys Res Commun. 2004;315(1):240-245.